أعرض في EDS

382P Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) treatment with panitumumab (P) and chemotherapy (CT). PERSEIDA (Idylla Cohort) study

التفاصيل البيبلوغرافية
العنوان:	382P Sequential RAS mutation status evaluation in circulating free DNA (cfDNA) in RAS wild type (wt) metastatic colorectal cancer (mCRC) patients (pt) starting first-line (1L) treatment with panitumumab (P) and chemotherapy (CT). PERSEIDA (Idylla Cohort) study
المؤلفون:	M. Valladares, M.J. Safont Aguileria, E. González-Flores, P. García Alfonso, A.M. López Muñoz, E. Aranda Aguilar, E. Falco Ferrer, N. Rodriguez-Salas, L. Cirera, M. Llanos-Munoz, J. Aparicio, P. Pimentel, A.O. Castillo Trujillo, M. Salgado Fernandez, M.A. Salud Salvia, R. Vidal Tocino, B. Massuti Sureda, R. Garcia-Carbonero, M.A.D.L.A. Vicente Conesa, A. Lloansi Vila
المصدر:	Annals of Oncology. 33:S711
بيانات النشر:	Elsevier BV, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Oncology, Hematology
تدمد:	0923-7534
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::f91148eac33b216af483137fdcc2862a https://doi.org/10.1016/j.annonc.2022.07.520
حقوق:	CLOSED
رقم الأكسشن:	edsair.doi...........f91148eac33b216af483137fdcc2862a
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	09237534